EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.21.47 | complement component C3 + H2O |
interaction studies with decay-accelerating factor DAF mediating decay of the alternative pathway C3 convertase, C3bBb, but not of the inactive proenzyme C3bB |
Homo sapiens |
complement component C3a + complement component C3b |
- |
? |
3.4.21.47 | complement component C3 + H2O |
potencies of the amplification loop of the alternative complement pathway summarized |
Homo sapiens |
complement component C3a + complement component C3b |
- |
? |
3.4.21.47 | complement component C3 + H2O |
properdin-deficient patients susceptible to lethal meningococcal infection, studies on yet unknown mechanism of selective predisposition |
Homo sapiens |
complement component C3a + complement component C3b |
- |
? |
3.4.21.47 | complement component C3 + H2O |
studies on fluid-phase formation of initial convertase by fluorescence resonance energy transfer (FRET) |
Homo sapiens |
complement component C3a + complement component C3b |
- |
? |
3.4.21.47 | complement component C3 zymogen + H2O |
- |
Homo sapiens |
complement component C3b + complement component C3a |
- |
? |
3.4.21.47 | complement component C3 zymogen + H2O |
activation |
Homo sapiens |
complement component C3b + complement component C3a |
- |
? |
3.4.21.47 | complement component C5 + H2O |
- |
Homo sapiens |
complement component C5a + complement component C5b |
- |
? |
3.4.21.47 | complement component C5 + H2O |
- |
Mus musculus |
complement component C5a + complement component C5b |
- |
? |
3.4.21.47 | complement component C5 + H2O |
methionine-modified enzyme has significantly lower C5-cleavage ability than that of unmodified enzyme |
Homo sapiens |
complement component C5a + complement component C5b |
- |
? |
3.4.21.47 | complement component C5 zymogen + H2O |
- |
Homo sapiens |
complement component C5b + complement component C5a |
- |
? |